MONITORING AND EVALUATION & RESEARCH

  India’s response to HIV epidemic is influenced by the available surveillance data, implementation capacities and   political commitment at state and national level. Apart from the sentinel surveillance, nationwide Computerised   Management Information System (CMIS) provides strategic information on programme monitoring and evaluation.

   Research

   Beginning NACP-III, NACO has positioned itself as the promoter and coordinator of research on HIV/AIDS not only in    India, but the entire South Asia region through partnership and networking with national academic and other institutions    in the region. This initiative will enhance NACO’s knowledge and evidence base of the various aspects of the epidemic

aTREATMENT

 HIV infection is not the end of life. People can lead a healthy life for a long time with appropriate medical care.     Anti-  retroviral therapy (ART)  effectively suppresses replication, if taken at the right time. Successful viral suppression   restores the immune system and halts onset and progression of disease as well as reduces chances of getting   opportunistic infections – this is how ART is aimed to work. Medication thus enhances both quality of life and longevity.

  Adherence to ART is Critical

  Adherence to ART regimen is therefore very vital in this treatment. Any irregularity in following the prescribed regimen   can lead to resistance to HIV drugs, and therefore can weaken or negate its effect.

  ART is Accessible to All  

  ART is now available free to all those who need it. Public health facilities are mandated to ensure that ART is provided to   people living with HIV/AIDS (PLHA). Special emphasis is given to the treatment of sero-positive women and infected   children.  

  When is ART Given?

  ART is initiated depending upon the stage of infection. PLHA with less than 200 CD4 (while blood cells/ mm3) require   treatment irrespective of the clinical stage. For PLHA with 200-350 CD4, ART is offered to symptomatic patients. Among   those with CD4 of more than 350, treatment is deferred for asymptomatic persons.   

  Criteria for ART

  CD4 (cell /mm3)

  Actions

  < 200

  Treat irrespective of clinical stage

  200 – 350

  Offer ART for symptomatic patients

  Initiate Rx before CD4 drop below 200   cells/mm3

  For Asymptomatic people *

  >350

  Defer treatment in asymptomatic persons

 

  * If CD4 is between 200-250, this should be repeated in four weeks and treatment to be considered in asymptomatic   patients.

  There are 127 ART centres operating in the country as of June 2007. By 2012, 250 ART centres will become functional   across the country in order to provide people living with HIV/AIDS better access to treatment.

  Where are these ART Centres Located?

   In order to make treatment more accessible ART centres are located in medical colleges, district hospitals and non-profit    charitable institutions providing care, support and treatment services to PLHA. A PLHA network person at each of the    ART centre facilitates access to care and treatment services at these centres. ART centres also provide counselling    and follow up on treatment adherence and support through community care centres.

   Paediatric Care and Support

   The primary goal of paediatric prevention, care and treatment programme is to prevent HIV infection to newborns    through Prevention of Parent to Child Transmission (PPTCT) and provide treatment and care to all children infected by    HIV.



Copyright ® 2012 manipursacs.nic.in

Website Developed and Hosted by NIC Manipur State Unit